1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow IC31 adjuvant: new trials by email Literature Review of IC31 adjuvant trials Research Report on IC31 adjuvant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Derivative (PPD) Positive Volunteers 50 microg. antigen + adjuvant (500 nmol KLK + 20 nmol ODN1a) - Tuberculosis | Phase 1 | Completed | Statens Serum Institut | 20 | 2007-09-01 | 2013-01-21 |
Tuberculosis (1)
Netherlands (1)
Jaap van Dissel, MD, Prof. (1)